Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional...
TandemAI announced it has raised $25 million in Seed and pre-Series A financing to advance its proprietary computational platform and expansion of its wet...
K2bio has announced Ansun BioPharma, a clinical-stage biopharmaceutical company, together with its wholly-owned subsidiary, Anovac, as an addition to the K2bio community. Ansun's mission...
SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics. Under...
Sorriso Pharmaceuticals, a company focused on transforming anti-inflammatory antibody therapy, announced the company has closed on a $31 million Series A financing. The round...
